Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2022 | Randomized phase II study of nalicap (nalIRI/capecitabine) compared to NAPOLI ( nal-IRI/5F-U/LV) in gemcitabine-pretreated advanced pancreatic cancer: Trial-in-progress | JOURNAL OF CLINICAL ONCOLOGY |